Health-Related Quality of Life Mildly Affected Following COVID-19: a Retrospective Pre-post Cohort Study with a Propensity Score-Matched Control Group.


Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
03 2022
Historique:
received: 18 06 2021
accepted: 15 12 2021
pubmed: 14 1 2022
medline: 12 3 2022
entrez: 13 1 2022
Statut: ppublish

Résumé

Long-term health effects have been indicated following COVID-19; however, the impact of COVID-19 on health-related quality of life (HRQOL), including who may experience ongoing symptoms, is unknown. To identify change in HRQOL following COVID-19 compared to pre-infection HRQOL and a matched control group, and identify predictors of patients who worsen. Retrospective pre-post cohort study with a matched control group. Large healthcare system in northeast Ohio. A total of 3,690 adult patients diagnosed with COVID-19 who completed HRQOL surveys during routine care for ambulatory visits before and after infection. Propensity-score 1:1 match was utilized to identify controls without COVID who completed HRQOL at two time points. HRQOL was assessed with PROMIS Global Health: global mental and physical health summary scores. Pre- and post-COVID PROMIS Global Health was completed as part of routine care from 1/1/2019 to 2/29/2020 and 4/4/2020 to 11/1/2021, respectively, and extracted from the electronic health record. COVID-19 patients (mean age 53±15; 66% female) completed PROMIS Global Health in the year prior (median 11.1 months) and after diagnosis (median 7.8 months). Compared to before infection, COVID-19 patients had a significant reduction in global mental health and stable global physical health (-0.85 and 0.05 T-score points, respectively) with clinically meaningful reduction (≥5 T-score points) experienced by 27% and 23% of patients, respectively. Predictors of worsening global health included being female, having depression, being hospitalized for COVID-19, and better pre-COVID global health. Compared to the control group, there was significantly worse global mental and physical health decline following COVID-19 (-0.53 and -0.37 T-score points, respectively). A quarter of patients with COVID-19 experienced meaningful reductions in HRQOL. Reductions in global mental and physical health were modest, although significantly worse than a control group. Additionally, identified predictors of patients who worsen may assist clinicians when counseling patients of their risk of worse HRQOL following COVID-19.

Identifiants

pubmed: 35025068
doi: 10.1007/s11606-021-07340-0
pii: 10.1007/s11606-021-07340-0
pmc: PMC8757401
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

862-869

Informations de copyright

© 2022. The Author(s) under exclusive licence to Society of General Internal Medicine.

Références

J Clin Epidemiol. 2010 Nov;63(11):1169-78
pubmed: 20688473
Travel Med Infect Dis. 2021 Mar-Apr;40:101995
pubmed: 33631340
Clin Microbiol Infect. 2021 Feb;27(2):258-263
pubmed: 33031948
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Brain Behav Immun. 2020 Oct;89:587-593
pubmed: 32681866
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
BMC Med Res Methodol. 2017 Apr 28;17(1):78
pubmed: 28454568
J Gen Intern Med. 2021 Mar;36(3):738-745
pubmed: 33443703
Clin Infect Dis. 2021 Dec 6;73(11):e4058-e4063
pubmed: 33252665
Value Health. 2021 Nov;24(11):1578-1585
pubmed: 34711357
AMIA Annu Symp Proc. 2011;2011:683-92
pubmed: 22195124
Clin Microbiol Infect. 2020 Nov;26(11):1448-1449
pubmed: 32712242
JAMA Netw Open. 2020 Sep 1;3(9):e2019686
pubmed: 32876685
Qual Life Res. 2021 May;30(5):1389-1405
pubmed: 33389523
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Qual Life Res. 2009 Sep;18(7):873-80
pubmed: 19543809
Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Influenza Other Respir Viruses. 2021 May;15(3):345-351
pubmed: 33405338
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Int J Environ Res Public Health. 2021 Feb 19;18(4):
pubmed: 33669714
Nat Commun. 2020 Dec 4;11(1):6208
pubmed: 33277494
Psychiatry Res. 2020 Nov;293:113382
pubmed: 32829073
Am J Geriatr Psychiatry. 2021 Sep;29(9):881-894
pubmed: 33867224
BMC Infect Dis. 2021 Feb 1;21(1):134
pubmed: 33522907
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
J Infect. 2021 Apr;82(4):e31-e33
pubmed: 33373650
Chest. 2020 Oct;158(4):1364-1375
pubmed: 32533957
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098
pubmed: 33220049
Open Forum Infect Dis. 2021 Jan 05;8(2):ofab007
pubmed: 33614816
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Psychiatry Res. 2020 Oct;292:113345
pubmed: 32745794
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910
Thorax. 2021 Apr;76(4):399-401
pubmed: 33273026
Curr Psychol. 2021 Apr 21;:1-10
pubmed: 33897227
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238

Auteurs

Brittany Lapin (B)

Center for Outcomes Research and Evaluation, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. LapinB@ccf.org.
Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. LapinB@ccf.org.

Irene L Katzan (IL)

Center for Outcomes Research and Evaluation, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH